Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Repurposing quinacrine for treatment-refractory cancer
Derek B. Oien et al.
SEMINARS IN CANCER BIOLOGY (2021)
Alkaliptosis: a new weapon for cancer therapy
Jiao Liu et al.
CANCER GENE THERAPY (2020)
Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma
Patricia M. LoRusso et al.
PIGMENT CELL & MELANOMA RESEARCH (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Autophagy and autophagy-related proteins in cancer
Xiaohua Li et al.
MOLECULAR CANCER (2020)
Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors
Subashini Sharon Gnanendran et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Diagnosis and treatment of melanoma bone metastasis: A multidisciplinary approach
Antonio Caldaria et al.
DERMATOLOGIC THERAPY (2020)
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
Faiqa Mudassar et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Optimal treatment strategy for metastatic melanoma patients harboringBRAF-V600mutations
Emilio Francesco Giunta et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Phospholipase A2 catalysis and lipid mediator lipidomics
Varnavas D. Mouchlis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)
Immunotherapy of Melanoma: Facts and Hopes
Sarah A. Weiss et al.
CLINICAL CANCER RESEARCH (2019)
The molecular machinery of regulated cell death
Daolin Tang et al.
CELL RESEARCH (2019)
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
Eduardo Jose Barbosa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Management of V600E and V600K BRAF-Mutant Melanoma
Alexandra M. Haugh et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
Matthew Dankner et al.
ONCOGENE (2018)
Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma
Jorine de Haan et al.
CASE REPORTS IN ONCOLOGY (2018)
Dynamics of p53: A Master Decider of Cell Fate
Qingyin Luo et al.
GENES (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells
Xiaoxu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cancer incidence and mortality in China, 2013
Wanqing Chen et al.
CANCER LETTERS (2017)
Ferrootosis: Death by Lipid Peroxidation
Wan Seok Yang et al.
TRENDS IN CELL BIOLOGY (2016)
Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer
Junjun Liu et al.
TUMOR BIOLOGY (2016)
Interpretation of immunohistochemistry data of tumor should consider microenvironmental factors
Huan Bian et al.
TUMOR BIOLOGY (2015)
Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
Ashwani Khurana et al.
ONCOTARGET (2015)
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Yonghe Li et al.
CANCER LETTERS (2014)
Anticancer Effects of Niclosamide in Human Glioblastoma
Anja Wieland et al.
CLINICAL CANCER RESEARCH (2013)
Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) Activity
Min Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
Autophagy: Renovation of Cells and Tissues
Noboru Mizushima et al.
CELL (2011)
Caspase-1-induced pyroptotic cell death
Edward A. Miao et al.
IMMUNOLOGICAL REVIEWS (2011)
Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
Ulrike Sack et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Yanli Jin et al.
CANCER RESEARCH (2010)
New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents
Katerina Gurova
FUTURE ONCOLOGY (2009)
A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion
Michael Overholtzer et al.
CELL (2007)
The p53 pathway: positive and negative feedback loops
SL Harris et al.
ONCOGENE (2005)
Share Paper
